Phenytoin

Product NDC: 59762-0531
11-digit product format: 597620531
Labeler code: 59762
Product ID: 59762-0531_212141a3-fffd-49e0-96d5-57cc921a99d1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Phenytoin
Dosage form: SUSPENSION
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: NDA008762
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2020-04-22
Substance: PHENYTOIN
Active strength: 125 mg/5mL
Pharmacologic classes: Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 10 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N008762-001	DILANTIN-125	PHENYTOIN	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982
N008762-002	DILANTIN-30	PHENYTOIN	30MG/5ML	SUSPENSION / ORAL		Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N008762-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N008762-001	DILANTIN-125	125MG/5ML	SUSPENSION / ORAL	AB	RLD, RS, Approved before 1982	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N008762-002	DILANTIN-30	30MG/5ML	SUSPENSION / ORAL		Approved before 1982	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N008762-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N008762-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N008762-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N008762-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N008762-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N008762-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N008762-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N008762-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N008762-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N008762-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N008762-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N008762-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N008762-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N008762-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N008762-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N008762-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N008762-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N008762-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N008762-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N008762-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N008762-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N008762-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N008762-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N008762-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N008762-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N008762-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N008762-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N008762-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N008762-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N008762-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N008762-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N008762-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N008762-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N008762-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N008762-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N008762-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N008762-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N008762-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N008762-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N008762-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Phenytoin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PHENYTOIN	125 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6158TKW0C5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1313112	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
37943ec1-a8d2-42df-967e-6f96f84c017b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
be8c0c29-be12-4cae-8e3b-1c71ed6b952c	Product name	2	20250626
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
e3d31abf-5149-4e77-89a8-0dc73ec106f9	Product name	1	20210525
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
b251e19b-cfda-4a5c-8c9c-f4dad5d55ecb	Product name	2	20200303
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
031bbc61-0564-1f35-2716-aa5c1d139248	Product name	2	20141218
cc830ceb-037c-a5c3-ee14-3d82c0e89e70	Product name	1	20140508
eafc3fd3-6834-3129-5bbb-8a9a495691ab	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59762-0531-2	Phenytoin	1 in 1 CARTON	SUSPENSION	1		31
59762-0531-2	Phenytoin	237 mL in 1 BOTTLE, PLASTIC	SUSPENSION	237		31

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59762-0531-1	ML - Milliliter	59762-0531	6bc19a70-2c0d-437c-9ca1-28dd3d03b6e6	1	2013-02-13
59762-0531-2	ML - Milliliter	59762-0531	d79c9764-a7ae-4f3d-923b-76e8b8cf3678	1	2020-07-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PHENYTOIN	ACTIVE INGREDIENT	6158TKW0C5	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
PHENYTOIN	ACTIVE MOIETY	6158TKW0C5	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	INACTIVE INGREDIENT	K679OBS311	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
MAGNESIUM ALUMINUM SILICATE	INACTIVE INGREDIENT	6M3P64V0NC	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
POLYSORBATE 40	INACTIVE INGREDIENT	STI11B5A2X	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
VANILLIN	INACTIVE INGREDIENT	CHI530446X	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8
WATER	INACTIVE INGREDIENT	059QF0KO0R	PHENYTOIN SUSPENSION [GREENSTONE LLC]	8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59762-0531	PHENYTOIN SUSPENSION [MYLAN PHARMACEUTICALS INC.]	31	Current NDC, Legacy NDC, 2 package rows	20250503_37943ec1-a8d2-42df-967e-6f96f84c017b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Phenytoin	PHENYTOIN	Mylan Pharmaceuticals Inc.	37943ec1-a8d2-42df-967e-6f96f84c017b	2024-12-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 008762 application number: NDA008762 ndc (product): 59762-0531
Dilantin-125	PHENYTOIN	Viatris Specialty LLC	f339f9e4-b289-4efe-82b9-46c57d1dc277	2023-02-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 008762 application number: NDA008762

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6158TKW0C5	PHENYTOIN	57-41-0	PHENYTOIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1313112	phenytoin 125 MG in 5 mL Oral Suspension	PSN	37943ec1-a8d2-42df-967e-6f96f84c017b	31
1313112	phenytoin 25 MG/ML Oral Suspension	SCD	37943ec1-a8d2-42df-967e-6f96f84c017b	31
1313112	DPH 25 MG/ML Oral Suspension	SY	37943ec1-a8d2-42df-967e-6f96f84c017b	31
1313112	phenytoin 100 MG per 4 ML Oral Suspension	SY	37943ec1-a8d2-42df-967e-6f96f84c017b	31
1313112	phenytoin 125 MG per 5 ML Oral Suspension	SY	37943ec1-a8d2-42df-967e-6f96f84c017b	31

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
59762-0531-2	59762053102	1 BOTTLE, PLASTIC in 1 CARTON (59762-0531-2) / 237 mL in 1 BOTTLE, PLASTIC	2020-04-22	0000-00-00	No	No	Current